Bowder Alexis N, Yen Christina F, Bebell Lisa M, Fernandes Alisha R
Department of Surgery, Medical College of Wisconsin, 8701 W Watertown Plank Rd, Wauwatosa, WI 53226, USA.
Beth Israel Deaconess Medical Center, Division of Infectious Diseases, 300 Longwood Ave, Boston, MA 02115, USA.
Ann Med Surg (Lond). 2021 Jun 16;67:102401. doi: 10.1016/j.amsu.2021.102401. eCollection 2021 Jul.
Surgical site infection (SSI) is common in colorectal surgery patients and associated with morbidity and mortality. Guidelines recommend preoperative intravenous antimicrobial prophylaxis with aerobic and anaerobic coverage to reduce SSI risk. Cephalosporin based prophylaxis (CBP) regimens are recommended as first-line prophylaxis, and non-cephalosporin based are recommended as alternative prophylaxis (AP). We evaluate the efficacy of CBP versus AP in preventing surgical site infections in colorectal surgery patients.
A systematic review and meta-analysis was conducted of studies published between 2005 and 2020 in MEDLINE and Web of Science. Studies were excluded if intravenous antimicrobial prophylaxis was not administered, or if oral and intravenous prophylaxis were routinely co-administered. Heterogeneity was reported using the Q-statistic and I-statistic. Publication bias was evaluated using a funnel plot and Egger test for small study effects. Statistical significance was defined as a two-sided < 0.05.
11 studies met inclusion criteria. AP was not associated with increased SSI risk at 30 days compared to CBP (OR 1.01, 95% CI 0.91, 1.13; OR < 1 favors AP). There was no effect size variability in subgroup analysis comparing higher-to lower-quality studies (I = 99%, = 0.17). Subgroup analysis by publication year approached a significant difference in effect size between studies published prior to 2014 and later than 2014 (I = 99%, = 0.06).
Meta-analysis of 11 studies of SSI risk in adult colorectal surgery patients suggest that SSI risk is similar for patients receiving CBP or AP, subgroup analysis of studies published since 2014 suggest increased SSI risk with AP compared to CBP.
手术部位感染(SSI)在结直肠手术患者中很常见,且与发病率和死亡率相关。指南建议术前静脉应用覆盖需氧菌和厌氧菌的抗菌药物进行预防,以降低SSI风险。基于头孢菌素的预防方案(CBP)被推荐作为一线预防措施,而非头孢菌素类预防方案被推荐作为替代预防措施(AP)。我们评估了CBP与AP在预防结直肠手术患者手术部位感染方面的疗效。
对2005年至2020年发表在MEDLINE和科学网的研究进行系统评价和荟萃分析。如果未进行静脉抗菌药物预防,或常规同时使用口服和静脉预防药物,则排除相关研究。使用Q统计量和I统计量报告异质性。使用漏斗图和Egger检验评估小研究效应的发表偏倚。统计学显著性定义为双侧P<0.05。
11项研究符合纳入标准。与CBP相比,AP在30天时与SSI风险增加无关(比值比1.01,95%置信区间0.91,1.13;比值比<1支持AP)。在比较高质量和低质量研究的亚组分析中,效应大小没有差异(I=99%,P=0.17)。按发表年份进行的亚组分析显示,2014年之前和2014年之后发表的研究在效应大小上接近显著差异(I=99%,P=0.06)。
对11项关于成人结直肠手术患者SSI风险的研究进行荟萃分析表明,接受CBP或AP的患者SSI风险相似,对2014年以来发表的研究进行亚组分析表明,与CBP相比,AP会增加SSI风险。